0001179110-15-010914.txt : 20150706
0001179110-15-010914.hdr.sgml : 20150703
20150706163450
ACCESSION NUMBER: 0001179110-15-010914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150706
DATE AS OF CHANGE: 20150706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REARDON WILLIAM S
CENTRAL INDEX KEY: 0001212646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 15973880
MAIL ADDRESS:
STREET 1: 9 STEAMBOAT LANE
CITY: HINGHAM
STATE: MA
ZIP: 02043
4
1
edgar.xml
FORM 4 -
X0306
4
2015-07-01
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001212646
REARDON WILLIAM S
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2015-07-01
4
A
0
5681
0
A
47120
D
Common Stock
2015-07-01
4
A
0
2272
0
A
49392
D
Director Stock Option (Right to Buy)
2.2
2015-07-01
4
A
0
20000
0
A
2025-07-01
Common Stock
20000
20000
D
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as Chairman of the Audit Committee of the Board of Directors of the Issuer on such date.
The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date.
/s/ Garrett M. Winslow, Attorney-in-Fact
2015-07-06